Opus Genetics, Inc.
IRD$329M
Small CapNASDAQPharmaceutical Preparations🇺🇸North AmericaDURHAM18 employees
Drugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Jan 20, 2027
44wMarket Overview
Stock performance and key metrics
IRD News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
AAV8.hLCA5 | Phase 2 | LCA5 | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply